The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...

Paris-based drugmaker Sanofi is acquiring U,K,-based Vicebio to gain its molecular clamp vaccine technology, with the total ...

Kangstem Biotech is showing weakness in early trading on 11th. Investors appear to be dumping shares due to concerns about adverse effects on stock prices following the announcement of a large ...

GM's EVs were popular in the second quarter, a complete contrast to the struggles by Ford, Tesla, Hyundai, and Kia to grow electric vehicle sales.

A copy of a ₹2-lakh Hermès sandal is listed for ₹599 on one platform while replicas of Tory Burch handbags appear on another. Weak law enforcement not only damages brands but also hurts India ...

Newsweek analyzed Elon Musk's public statements to decipher what an America Party would stand for and who could get involved.

Beyond politics: Growing Kenya’s economy by empowering farmers.

OpenAI's CEO believes that AI systems will be capable of figuring out "novel insights" in 2026, he said in a blog post.

The government should invest R&D funding strategically in discovery science, connect regional R&D hubs into a national innovation ecosystem and collaborate with partners abroad.